We show that by inhibiting the elevated levels of miR-570-3p in SAECs from patients with COPD, we can increase cellular proliferation while reducing the expression of many key SASP proteins (MMP-2/9, IL-1β, CXCL8, and IL-6). This evidence concerns the gene CXCL8 and chronic obstructive pulmonary disease.